Literature DB >> 5009021

Encephalomyelopathy with hepatic cirrhosis following portosystemic venous shunts.

L G Lefer, F S Vogel.   

Abstract

Entities:  

Mesh：

Year:  1972        PMID： 5009021

Source DB:  PubMed          Journal:  Arch Pathol        ISSN： 0363-0153


× No keyword cloud information.
  7 in total

1.  Hepatic myelopathy: an unusual neurological complication of chronic liver disease presenting as quadriparesis.

Authors:  Prakash Kori; Ritesh Sahu; Anupam Jaiswal; Rakesh Shukla
Journal:  BMJ Case Rep       Date:  2013-06-07

2.  Liver transplantation in hepatic myelopathy.

Authors:  Sencan Acar; Ayhan Dinckan; Murat Akyildiz
Journal:  Hepatol Forum       Date:  2022-04-26

3.  Degeneration of the corticospinal tract following portosystemic shunt associated with spinal cord infarction.

Authors:  F Giangaspero; C Dondi; P Scarani; G Zanetti; G Marchesini
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

Review 4.  Spinal cord involvement in patients with cirrhosis.

Authors:  Raffaele Nardone; Yvonne Höller; Monica Storti; Piergiorgio Lochner; Frediano Tezzon; Stefan Golaszewski; Francesco Brigo; Eugen Trinka
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

Review 5.  Human alcohol-related neuropathology.

Authors:  Suzanne M de la Monte; Jillian J Kril
Journal:  Acta Neuropathol       Date:  2013-12-27       Impact factor: 17.088

6.  Hepatic myelopathy in a patient with decompensated alcoholic cirrhosis and portal colopathy.

Authors:  Madhumita Premkumar; Avishek Bagchi; Neha Kapoor; Ankit Gupta; Gaurav Maurya; Shubham Vatsya; Siddharth Kapahtia; Premashish Kar
Journal:  Case Reports Hepatol       Date:  2012-12-18

7.  Regional gray matter abnormality in hepatic myelopathy patients after transjugular intrahepatic portosystemic shunt: a voxel-based morphometry study.

Authors:  Kang Liu; Gang Chen; Shu-Yao Ren; Yuan-Qiang Zhu; Tian-Lei Yu; Ping Tian; Chen Li; Yi-Bin Xi; Zheng-Yu Wang; Jian-Jun Ye; Guo-Hong Han; Hong Yin
Journal:  Neural Regen Res       Date:  2019-05       Impact factor: 5.135
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.